United States · FDA National Drug Code directory
Deferoxamine mesylate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68083-173_d14a31c5-4e8d-4e3e-b38f-d73ffddfb629
- Product NDC
- 68083-173
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Deferoxamine mesylate
- Labeler
- Gland Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171009
- Source listing expiry
- 20271231
Source-listed ingredients
- DEFEROXAMINE MESYLATE — 2 g/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (68083-173-01) · 68083-173-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →